Double suicide genes selectively kill human umbilical vein endothelial cells

Virology Journal

Volumn 8, Issue , 2011, Pages

  Jia, Weiguo ^a   Mei, Longyong ^a   Wang, Yanping ^a   Liu, Lunxu ^a   Che, Guowei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CYTOSINE DEAMINASE; CYTOSINE DEAMINASE THYMIDINE KINASE FUSION PROTEIN; FLUCYTOSINE; FLUORESCEIN ISOTHIOCYANATE; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LIPOCORTIN 5; THYMIDINE KINASE; TRANSFERASE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC GENE THERAPY; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CELL CULTURE; CELL GROWTH; CELL KILLING; CELL STRAIN HEPG2; CELL SURVIVAL; CYTOTOXICITY; DRUG EFFICACY; ESCHERICHIA COLI; FUSION GENE; GENE EXPRESSION; GROWTH INHIBITION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LIVER CANCER; MOLECULAR CLONING; SUICIDE GENE; UMBILICAL VEIN ENDOTHELIAL CELL; ADENOVIRUS; DRUG EFFECT; ENDOTHELIUM CELL; GENE THERAPY; GENE VECTOR; GENETICS; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROMOTER REGION; SUICIDE TRANSGENE; TUMOR CELL LINE; VIROLOGY;

ADENOVIRIDAE; ESCHERICHIA COLI; SIMPLEXVIRUS;

ADENOVIRIDAE; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; ENDOTHELIAL CELLS; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS, GENETIC; RECOMBINANT FUSION PROTEINS; THYMIDINE KINASE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 79951687004     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-74     Document Type: Article

References (21)

1. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. F Bertolini Y Shaked P Mancuso RS Kerbel, Nat Rev Cancer 2006 6 835 845 10.1038/nrc1971 17036040 (Pubitemid 44629895)
2. Antiangiogenic gene therapy for cancer treatment. AM Davidoff AC Nathwani, Curr Hematol Rep 2004 3 267 273 15217556
3. Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. C Patterson MA Perrella CM Hsieh M Yoshizumi ME Lee E Haber, J Biol Chem 1995 270 23111 231118 10.1074/jbc.270.39. 23111 7559454
4. A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy. PD Boucher MM Im SO Freytag DS Shewach, Cancer Res 2006 66 3230 3237 10.1158/0008-5472.CAN-05-3033 16540675
5. Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model. S Moriuchi D Wolfe M Tamura T Yoshimine F Miura JB Cohen JC Glorioso, Gene Ther 2002 9 584 591 10.1038/sj.gt.3301693 11973634 (Pubitemid 34567775)
6. Killer genes in pancreatic cancer therapy. P Fogar E Greco D Basso F Navaglia M Plebani S Pedrazzoli, Cell Mol Biol (Noisy-le-grand) 2005 51 61 76 16171565 (Pubitemid 43102286)
7. Characterization of the human p11 promoter sequence. Huang Xiuli Pawliczak Rafal Yao Xiang-Lan Madara Patricia Alsaaty Sura Shelhamera H James Cowan J Mark, Gene 2003 310 133 142 10.1016/S0378-1119(03)00529-8 12801640
8. Antiangiogenic effects of butyric acid involve inhibition of VEGF/KDR gene expression and endothelial cell proliferation. AE Gururaj M Belakavadi BP Salimath, Mol Cell Biochem 2003 243 107 112 10.1023/A:1021647726366 12619895 (Pubitemid 36240557)
9. Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins. KJ Higgins M Abdelrahim S Liu K Yoon S Safe, Biochem Biophys Res Commun 2006 23 345 292 301 10.1016/j.bbrc.2006.04.111 (Pubitemid 44269283)
10. Expression of c-kit, Flk-1, and Flk-2 receptors in benign and malignant tumors of follicular epithelial origin. SP Kung CH Lee AH Yang CW Chi LM Tseng CW Wu, J Chin Med Assoc 2006 69 74 79 10.1016/S1726-4901(09)70117-0 16570574
11. Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas. SA Kaliberov LN Kaliberova DJ Buchsbaum, Gene Ther 2005 12 5 407 417 10.1038/sj.gt.3302432 15616600 (Pubitemid 40394293)
12. Antiangiogenic therapy for the treatment of pediatric solid malignancies. AM Davidoff JJ Kandel, Semin Pediatr Surg 2004 13 53 60 10.1053/j.sempedsurg. 2003.09.008 14765371 (Pubitemid 38233859)
13. Targeted measles virus vector displaying echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regression. LK Hallak JR Merchan CM Storgard JC Loftus SJ Russell, Cancer Res 2005 65 5292 5300 10.1158/0008-5472. CAN-04-2879 15958576 (Pubitemid 40827341)
14. Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization. KR Rogulski MS Wing DL Paielli JD Gilbert JH Kim SO Freytag, Hum Gene Ther 2000 11 67 76 10.1089/10430340050016166 10646640 (Pubitemid 30044041)
15. Experimental study on the transcriptional targeting gene therapy of double suicide gene driven by KDR promoter in lung cancer. CHE Guowei ZHOU Qinghua LIU Lunxu BU Hong WANG Yanping ZHU wen CHEN Xiaohe TANG xiaojun, Science and Technology Review 2006 24 28 31
16. Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. U Fischer S Steffens S Frank NG Rainov K Schulze-Osthoff CM Kramm, Oncogene 2005 24 1231 43 10.1038/sj.onc.1208290 15592511 (Pubitemid 40313924)
17. Kinase domain insert containing receptor promoter controlled suicide gene system selectively kills human umbilical vein endothelial cells. WY Yang ZH Huang LJ Lin Z Li JL Yu HJ Song Y Qian XY Che, World J Gastroenterol 2006 12 5331 5335 16981263 (Pubitemid 44501777)
18. Cancer gene therapy: combination with radiation therapy and the role of bystander cell killing in the anti-tumor effect. K Lumniczky G Safrany, Pathol Oncol Res 2006 12 118 124 10.1007/BF02893457 16799716 (Pubitemid 44197182)
19. Antitumor effects and radiosensitization of cytosine deaminase and thymidine kinase fusion suicide gene on colorectal carcinoma cells. DH Wu L Liu LH Chen, World J Gastroenterol 2005 11 3051 3055 15918188 (Pubitemid 40790661)
20. Engineered adenovirus serotypes for overcoming anti-vector immunity. S Dharmapuri D Peruzzi L Aurisicchio, Expert Opin Biol Ther 2009 9 1279 1287 10.1517/14712590903187053 19645630
21. Adenovirus-adeno-associated virus hybrid for large-scale recombinant adeno-associated virus production. H Zhang J Xie Q Xie JM Wilson G Gao, Hum Gene Ther 2009 20 922 929 10.1089/hum.2009.125 19618999